Sheila M. Fleming

Department of Psychology, University of Cincinnati

Research Area

Biography

Sheila M. Fleming has not added Biography.
If you are Sheila M. Fleming and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 170	2013
Publication title Cited by 107	2014

Other Publications

Article	Year
Intravenous ethanol/cocaine self-administration initiates high intake of intravenous ethanol alone. Pharmacology, biochemistry, and behavior\| PubMed ID: 12062567	2002
Should the injured and intact hemispheres be treated differently during the early phases of physical restorative therapy in experimental stroke or parkinsonism? Physical medicine and rehabilitation clinics of North America\| PubMed ID: 12625636	2003
Experimental focal ischemic injury: behavior-brain interactions and issues of animal handling and housing. ILAR journal / National Research Council, Institute of Laboratory Animal Resources\| PubMed ID: 12652008	2003
Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. The Journal of biological chemistry\| PubMed ID: 12930822	2003
Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Experimental neurology\| PubMed ID: 15144868	2004
Variable effects of chronic subcutaneous administration of rotenone on striatal histology. The Journal of comparative neurology\| PubMed ID: 15384065	2004
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect. Trends in neurosciences\| PubMed ID: 15474170	2004
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 15496679	2004
An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate. Behavioural brain research\| PubMed ID: 15582106	2005
3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 15728853	2005
Genetic mouse models of parkinsonism: strengths and limitations. NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics\| PubMed ID: 16389313	2005
Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism. Behavioural pharmacology\| PubMed ID: 16940759	2006
Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association\| PubMed ID: 18037553	2008
Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein. Neuroreport\| PubMed ID: 18463504	2008
Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. The European journal of neuroscience\| PubMed ID: 18702696	2008
Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of p... The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 19228951	2009
Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 19549824	2009
Behavioral outcome measures for the assessment of sensorimotor function in animal models of movement disorders. International review of neurobiology\| PubMed ID: 19900615	2009
Mice overexpressing corticotropin-releasing factor show brain atrophy and motor dysfunctions. Neuroscience letters\| PubMed ID: 20132869	2010
HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease. Nature neuroscience\| PubMed ID: 21076425	2011
A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions. Molecular and cellular neurosciences\| PubMed ID: 21193046	2011
Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons. Molecular neurodegeneration\| PubMed ID: 22165993	2011
Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease. Behavioural brain research\| PubMed ID: 22178078	2012
Cognitive deficits in a mouse model of pre-manifest Parkinson's disease. The European journal of neuroscience\| PubMed ID: 22356593	2012
Cranial and related sensorimotor impairments in rodent models of Parkinson's disease. Behavioural brain research\| PubMed ID: 22394540	2012
Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited Î±-synuclein accumulation and age-dependent sensorimotor deficits. Human molecular genetics\| PubMed ID: 23393156	2013
Impaired baroreflex function in mice overexpressing alpha-synuclein. Frontiers in neurology\| PubMed ID: 23888153	2013
Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system. PloS one\| PubMed ID: 24312298	2013
Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigro... Neurobiology of disease\| PubMed ID: 24844147	2014
Ribosomal s15: A novel therapeutic target for Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society\| PubMed ID: 24865568	2014
A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics\| PubMed ID: 25037721	2014